ILLKIRCH, France & DIJON, France--(BUSINESS WIRE)--PhenoPro (Illkirch, France) and Oncodesign (Dijon, France) announced today their alliance to develop and market “OncOptima”. This new joint service integrates the design, the characterization, and the validation of genetically engineered mouse models to evaluate targeted therapies in cancer. This unique partnership combines PhenoPro’s broad capabilities and in-depth expertise in mouse model phenotyping, with Oncodesign leadership in preclinical services for translational research in cancer.
